Clinical and Metabolic Characterization of Long-term Courses of Obesity Patients
NCT ID: NCT04375371
Last Updated: 2021-06-07
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
117 participants
INTERVENTIONAL
2020-01-27
2020-10-23
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The aim of this study is to investigate the glycemic course (prediabetes, development of diabetes) of patients with obesity (BMI\>=35 kg/m2) who had undergone bariatric surgery compared to patients with obesity who have not. A further aim is to investigate predictors of weight development, development of body composition and insulin sensitivity of patients who had undergone bariatric surgery compared to obesity patients who have not undergone bariatric surgery. The long-term courses after different surgical procedures (Roux-Y vs Sleeve) will be compared.
In this study 300 patients with obesity who had been metabolically characterized in a previous study will be recruited.
These patients are examined (medical history, physical examination including ECG, BIA, weight, height) and metabolically characterized.
Participants without diabetes undergo a glucose tolerance test and fasting blood sampling will be performed in participants with diabetes. All patients complete questionnaires to activity, nutrition, life quality, impulsiveness, depression and eating behavior.
Randomly selected participants will be offered an abdominal fat tissue biopsy. When consent is given, this will be performed at least two days after the glucose tolerance test.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Effect of Bariatric Surgery on Insulin Sensitivity and Energy Metabolism
NCT01477957
Effect of Bariatric Surgery on Brain Insulin Sensitivity
NCT03705923
Complications After Bariatric Surgery Based, a Questionnaire Survey
NCT01930851
Early Changes of Diabetes Parameters After Obesity Therapy
NCT02553213
Complications After Bariatric Surgery - a Clinical Trial
NCT01930838
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
PARALLEL
BASIC_SCIENCE
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Obese patients who have received a bariatric surgery
Obese patients who have undergone a bariaric surgery as part of routine clinical management within the indication of this intervention.
Bariatric surgery
Obese patients who haveundergone bariatric surgery as part of routine clinical management within the indication of this intervention.
Obese patients without a bariatric surgery
Obese patients who have not undergone bariaric surgery.
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Bariatric surgery
Obese patients who haveundergone bariatric surgery as part of routine clinical management within the indication of this intervention.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Women during pregnancy and lactation
* Patients who are unable to give their consent
* Patients who have undergone surgery within the last 3 months
* acute disease or infection within the last 4 months
* HIV- or hepatitis B/C-positive
* for biopsy of fat tissue: known coagulation disorder or PTT or INR out of reference range
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University Hospital Tuebingen
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Robert Wagner, PD Dr.
Role: PRINCIPAL_INVESTIGATOR
University of Tuebingen, Department of Internal Medicine IV
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of Tuebingen, Department of Internal Medicine IV
Tübingen, , Germany
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
338/2019BO1
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.